PRECISION BIOSCIENCES INC (DTIL)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends May 21
In fiscal 2025, PRECISION BIOSCIENCES INC reported revenue of $34.26M, down 50.1% from the prior year. The company ran a net loss, with a net margin of -133.4%. It held $154.42M in total assets against $62.17M in total liabilities.
Key ratios (FY2025)
-152.2%
Operating margin
-133.4%
Net margin
-49.6%
Return on equity
-50.1%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $34.26M | $68.70M | $48.73M | $25.10M | $115.53M | $24.29M | $22.24M | $10.88M | — |
| Operating Income | -$52.15M | -$26.16M | -$43.74M | -$62.31M | -$39.38M | -$109.83M | -$87.20M | -$47.91M | — |
| Net Income | -$45.72M | $7.17M | -$61.32M | -$111.64M | -$30.60M | -$109.01M | -$92.88M | -$46.04M | — |
| EPS (Diluted) | $-3.56 | $1.04 | $-15.96 | $-38.10 | $-0.52 | — | — | — | — |
| Total Assets | $154.42M | $136.39M | $159.78M | $238.17M | $211.50M | $150.16M | $235.23M | $138.60M | — |
| Total Liabilities | $62.17M | $80.00M | $140.92M | $177.74M | $120.33M | $105.73M | $96.92M | $98.64M | — |
| Shareholders' Equity | $92.25M | $56.39M | $18.86M | $60.43M | $91.17M | $44.42M | $138.31M | $39.96M | -$26.37M |
| Cash & Equivalents | $110.82M | $85.90M | $116.68M | $189.58M | $143.66M | $89.80M | $180.89M | $103.19M | — |
| Operating Cash Flow | -$65.84M | -$58.45M | -$84.11M | -$45.75M | -$10.85M | -$87.39M | -$71.02M | -$51.72M | — |
| Capital Expenditures | $85.0K | $250.0K | $1.96M | $3.32M | $5.05M | $5.03M | $24.67M | $14.28M | — |
| Shares Outstanding | 24.09M | 8.20M | 4.16M | 3.70M | 60.90M | 52.69M | 51.16M | 15.91M | — |